Peer Review History
| Original SubmissionMay 16, 2021 |
|---|
|
PONE-D-21-16131Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative studyPLOS ONE Dear Dr. AlBurno, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by two reviewers, and their comments are available below. The reviewers’ comments raise some overlapping concerns about additional detail and clarification of the methodology and statistical analyses, in addition to further depth of discussion in the Introduction and Discussion. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Apr 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Avanti Dey, PhD Staff Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. You indicated that you had ethical approval for your study. In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a well written article which I enjoyed reading. In many ways the experiences of those living with type 1 diabetes in Qatar are similar to those in my own country of the UK. The heat is probably not a limit of physical activity however! There are some things that could improve the article. (1) Excepting direct quotes, please do not use the term diabetics (a disease condition should not be used to define a person). Please amend to people living with diabetes throughout. As the title explains that this work is in Type 1 diabetes, 'people living with diabetes should suffice. (2) In the table of quotes, please define by age and sex but also by adherent, non adherent - it is vaguely irritating to have to go back to quote to identify status (3) I am not quite certain I know how adherent and non-adherent was defined ? Was this by physician referral in purposive sampling, if so what criteria were used? Or was it by direct questioning initially in interview -again by what criteria? (4) In insulin administration technique (table 2) - just use injectable pen (not disposable pen - quite a few insulins do not throw away pen, they replace cartridge) (5) Could the English be reviewed please using a English language review tool? An example being line 449 Quite few non-adherent, should be Quite a few non-adherent. There are a few other examples but overall the English used in text is of very high quality. (6) I am struck by Healthy Eating, do young people living with diabetes in Qatar use carbohydrate counting as technique. Can this be clarified please as it is the basis of dietary management in many countries now for diabetes with healthy eating on top of that, all guided by dietician sessions. (7) In the limitations: do the authors feel that only having two patients with optimal control had an impact, as that seems like purposive sampling did not recruit sufficient to me - if you have five adherent but only two with optimal control which isn't that tight - we set 48mmol/mol for that now, it seems they may not in fact be that adherent? Please comment further on this observation. Reviewer #2: Thank you for the opportunity to review your manuscript. The exploration of determinants for healthy eating and physical activity for AYAs with T1D is an important area of study and will likely be of interest to readers. Although the qualitative design is a strength of the study, there are a few concerns that need to be addressed. I have outlined these below for each section of the paper. Introduction: 1) Please elaborate a bit more on how this study will be different than what others have done before. a. The authors make the claim that not much work has been done with AYA in Qatar. b. This is important, but please elaborate on this argument. What benefits would it have? What differences might you expect? Are there any important cultural expectations that might drive findings to be different from other publications? 2) Likewise, strengthen the argument for why qualitative work needs to be done. 3) Lines 110-126: Provide more research evidence for the model as it is used in predicting diabetes self-care behaviors. The authors describe the model, but add more citations/research support for the successful use of it in diabetes behaviors. Methods: 1) Lines 141-142: Please clarify why the requirement for participants to be receiving insulin therapy for at least 2 months was made. That is - please add support for how 2 months is a significant amount of time to establish self-care behavior routines. 2) Describe in more detail how reliability and validity are established in this form of qualitative data analysis and coding process. 3) Please provide more detail about how adherence was measured. Was is just adherence to PA and HE? Or adherence to all recommended self-care behaviors? How did you determine who was considered "adherent" or "non-adherent"? Results: 1) Quotes should be shared throughout the text rather than in a table. It was cumbersome to go back and forth between the written text and the table to read about the evidence. It made the story you are telling feel a bit disjointed. a. Please note that this might be a journal requirement and if it is, then please disregard. 2) Overall, I think more quotes are needed to support some of the general results you are making. These are the bread and butter of qualitative work and what make the work interesting to read. Readers want to hear the voice of the participants, please include more. Here are sections I have identified that could use supporting quotes: a. Line 231 - provide quotes of those who reported being adherent to PA and HE. b. Lines 247-249: c. Lines 270-272 d. 317-318 e. 384-387 f. 410-414 3) Please describe how you handled double codes )if any)? a. For example, the results of adherent parents findings PA easier when others went with (Lines 358-360) could also be coded as social influences (lines 290)? 4) Table 3 is a nice summary. Thank you for including it. Discussion: 1) Please describe how this study contributes something beyond what others have done. 2) Since the authors identify a need for this study based on the population, please bring that back into the discussion. What was similar to previous work? Anything new or insightful for this particular population? 3) Limitations may also include the different kinds of therapy that AYA with T1D use. It might be possible that participants who take shots have a different experience with HE and PA than those who are on an insulin pump system. Please include this in your limitations section. The recommendations section should be expanded a bit. This is where the research gets to help others. Please provide a few more specific recommendations based on some of the general findings of your work (e.g., including friends in PA and HE management might boost adherence, finding ways to increase awareness of risk…). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study PONE-D-21-16131R1 Dear Dr. Hanan AlBuno We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Enock Madalitso Chisati, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for addressing my comments in first review. The text now makes for an interesting addition to the literature on diabetes adherence in young people. Reviewer #2: My comments and issues with the manuscript have been adequately addressed. I do not have any further comments or concerns with the manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-21-16131R1 Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study Dear Dr. AlBurno: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Enock Madalitso Chisati Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .